Publikationen, an denen er mitarbeitet Joan Montaner Villalonga (16)

2024

  1. Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)

    Trials, Vol. 25, Núm. 1

2023

  1. Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol

    European Stroke Journal, Vol. 8, Núm. 1, pp. 380-386

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 1, pp. 1-14

2019

  1. PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis

    Circulation Research, Vol. 124, Núm. 1, pp. 114-120

  2. Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA

    Neurology, Vol. 93, Núm. 9, pp. e851-e863

2017

  1. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2016

  1. Combination of thrombolysis and statins in acute stroke is safe: Results of the STARS randomized trial (Stroke Treatment With Acute Reperfusion and Simvastatin)

    Stroke, Vol. 47, Núm. 11, pp. 2870-2873

2012

  1. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke

    Annals of Neurology, Vol. 72, Núm. 5, pp. 716-729

  2. IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke

    Stroke, Vol. 43, Núm. 10, pp. 2659-2665

  3. Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients

    Stroke, Vol. 43, Núm. 5, pp. 1398-1400

2010

  1. Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: A case-control, meta-analysis and functional study

    Cerebrovascular Diseases, Vol. 29, Núm. 6, pp. 528-537

  2. KCNK17 genetic variants in ischemic stroke

    Atherosclerosis, Vol. 208, Núm. 1, pp. 203-209

  3. The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals

    European Journal of Neurology, Vol. 17, Núm. 11, pp. 1390-1392